Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.762. It has been cited 16 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.337
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institutes of Health
Grant: 2RM1HG009490-06
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease
National Institutes of Health
Grant: 5R01GM065050-15
Atomic-Resolution Analysis of Translation Control
National Institutes of Health
Grant: 5R01AI136972-03
Genetic regulation and immunological function of ERAP2 haplotypes
National Institutes of Health
Grant: 5U01AI142817-04
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
National Institutes of Health
Grant: 5R35CA209919-02
LncRNA mechanisms in cancer
National Institutes of Health
Grant: 5F31HL156468-02
Characterization and engineering of a compact genome editor for adeno-associated virus delivery to correct mutations causing cystic fibrosis
National Institutes of Health
Grant: 5R01AR071522-04
Fine mapping rheumatic disease variants using functional genomic sequencing
National Institutes of Health
Grant: 5RM1HG007735-08
Center for Personal Dynamic Regulomes
Fields of Study
Keywords